Difference between revisions of "Team:UI Indonesia/Parts"

(Prototype team page)
 
 
(44 intermediate revisions by 3 users not shown)
Line 1: Line 1:
{{UI_Indonesia}}
+
{{Template:UI_Indonesia/css}}
<html>
+
  
 +
<html lang="en">
  
<div class="column full_size">
+
<head>
<h1>Parts</h1>
+
  <meta charset="UTF-8">
<p>Each team will make new parts during iGEM and will submit them to the Registry of Standard Biological Parts. The iGEM software provides an easy way to present the parts your team has created. The <code>&lt;groupparts&gt;</code> tag (see below) will generate a table with all of the parts that your team adds to your team sandbox.</p>
+
  <meta name="viewport" content="width=device-width, initial-scale=1.0">
<p>Remember that the goal of proper part documentation is to describe and define a part, so that it can be used without needing to refer to the primary literature. Registry users in future years should be able to read your documentation and be able to use the part successfully. Also, you should provide proper references to acknowledge previous authors and to provide for users who wish to know more.</p>
+
  <meta http-equiv="X-UA-Compatible" content="ie=edge">
</div>
+
  <link rel="stylesheet" href="https://www.w3schools.com/w3css/4/w3.css">
 +
  <link rel="stylesheet" href="https://fonts.googleapis.com/css?family=Lato">
 +
  <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/4.7.0/css/font-awesome.min.css">
 +
  <link rel="stylesheet" href="https://maxcdn.bootstrapcdn.com/bootstrap/3.3.7/css/bootstrap.min.css">
 +
</head>
  
<div class="column full_size">
+
<style>
<div class="highlight decoration_background">
+
  body,h1,h2,h3,h4,h5,h6 {font-family: "Lato", sans-serif;}
<h3>Note</h3>
+
  body, html {
<p>Note that parts must be documented on the <a href="http://parts.igem.org/Main_Page"> Registry</a>. This page serves to <i>showcase</i> the parts you have made. Future teams and other users and are much more likely to find parts by looking in the Registry than by looking at your team wiki.</p>
+
      height: 100%;
</div>
+
      color: #777;
</div>
+
      line-height: 1.5;
 +
  }
 +
  a {
 +
    color: white;
 +
  }
  
<div class="clear extra_space"></div>
+
  .mySlides {display: none}
<div class="line_divider"></div>
+
<div class="clear extra_space"></div>
+
  
 +
  .bgimg-3, .bgimg-4, .bgimg-5 {
 +
      background-attachment: fixed;
 +
      background-position: center;
 +
      background-repeat: no-repeat;
 +
      background-size: cover;
 +
  }
  
 +
  .bgimg-3 {
 +
      background-image: url("https://static.igem.org/mediawiki/2018/0/07/T--UI_Indonesia--bacteria.jpg");
 +
      min-height: 400px;
 +
  }
  
 +
  .bgimg-4 {
 +
      background-image: url("https://static.igem.org/mediawiki/2018/d/d2/T--UI_Indonesia--bgimg4.png");
 +
      min-height: 400px;
 +
  }
  
 +
  .bgimg-5 {
 +
      background-image: url("https://static.igem.org/mediawiki/2018/d/d2/T--UI_Indonesia--bgimg4.png");
 +
      min-height: 400px;
 +
  }
  
<div class="column two_thirds_size">
+
  @media only screen and (max-device-width: 1024px) {
<div class="highlight decoration_B_full">
+
      .bgimg-3, .bgimg-4, .bgimg-5 {
 +
          background-attachment: scroll;
 +
      }
 +
  }
  
<h3>Adding parts to the registry</h3>
+
  <!---- MT NAVBAR --->
<p>You can add parts to the Registry at our <a href="http://parts.igem.org/Add_a_Part_to_the_Registry">Add a Part to the Registry</a> link.</p>
+
.sidebar-nav {
 +
  padding: 9px 0;
 +
}
  
<p>We encourage teams to start completing documentation for their parts on the Registry as soon as you have it available. The sooner you put up your parts, the better you will remember all the details about your parts. Remember, you don't need to send us the DNA sample before you create an entry for a part on the Registry. (However, you <b>do</b> need to send us the DNA sample before the Jamboree. If you don't send us a DNA sample of a part, that part will not be eligible for awards and medal criteria.)</p>
+
.dropdown-menu .sub-menu {
<div class="button_link">
+
  left: 100%;
<a href="http://parts.igem.org/Add_a_Part_to_the_Registry">
+
  position: absolute;
ADD PARTS
+
  top: 0;
</a>
+
  visibility: hidden;
</div>
+
  margin-top: -1px;
 +
}
  
</div>
+
.dropdown-menu li:hover .sub-menu {
</div>
+
  visibility: visible;
 +
}
  
 +
.dropdown:hover .dropdown-menu {
 +
  display: block;
 +
}
  
 +
.nav-tabs .dropdown-menu,
 +
.nav-pills .dropdown-menu,
 +
.navbar .dropdown-menu {
 +
  margin-top: 0;
 +
}
  
<div class="column third_size">
+
.navbar .sub-menu:before {
<div class="highlight decoration_A_full">
+
  border-bottom: 7px solid transparent;
<h3>Inspiration</h3>
+
  border-left: none;
<p>We have a created  a <a href="http://parts.igem.org/Well_Documented_Parts">collection of well documented parts</a> that can help you get started.</p>
+
  border-right: 7px solid rgba(0, 0, 0, 0.2);
 +
  border-top: 7px solid transparent;
 +
  left: -7px;
 +
  top: 10px;
 +
}
  
<p> You can also take a look at how other teams have documented their parts in their wiki:</p>
+
.navbar .sub-menu:after {
<ul>
+
  border-top: 6px solid transparent;
<li><a href="https://2014.igem.org/Team:MIT/Parts"> 2014 MIT </a></li>
+
  border-left: none;
<li><a href="https://2014.igem.org/Team:Heidelberg/Parts"> 2014 Heidelberg</a></li>
+
  border-right: 6px solid #fff;
<li><a href="https://2014.igem.org/Team:Tokyo_Tech/Parts">2014 Tokyo Tech</a></li>
+
  border-bottom: 6px solid transparent;
</ul>
+
  left: 10px;
</div>
+
  top: 11px;
</div>
+
  left: -6px;
 +
}
  
 +
.dropdown>ul{
 +
background-color:#ddffdd;
 +
}
  
<div class="clear extra_space"></div>
+
.dropdown:hover{
 +
background-color:#9ff99f;
 +
}
 +
.navbar-header:hover{
 +
background-color:#4CAF50;
 +
}
 +
.dropdown-menu>li>a:hover{
 +
background-color:#4CAF50; 
 +
}
 +
.navbar-nav>li:hover{
 +
background-color:#4CAF50;
 +
}
  
 +
.navbar-default{
 +
background-color:#1F2421}
 +
border-color:none;
 +
}
 +
.navbar-default .navbar-brand:focus, .navbar-default .navbar-brand:hover{
 +
color:white;}
 +
.navbar-default .navbar-brand{
 +
color:white;}
 +
.navbar-default .navbar-nav>li>a{
 +
color:white;
 +
}
  
 +
.dropdown-menu{
 +
background-color:#ddffdd;
 +
}
 +
.current{
 +
    background-color:#4CAF50; 
 +
}
 +
.navbar-default .navbar-nav>.open>a{
 +
background-color:1F2421;color:white;}
  
 +
.navbar{
 +
margin:0px;border:0px;}
 +
h5{
 +
font-size:20px;
 +
text-align:justify;
 +
}
 +
h6{
 +
font-size:16px;
 +
}
 +
.ref{
 +
font-size:18px;
 +
}
 +
#myBtn {
 +
  display: none;
 +
  position: fixed;
 +
  bottom: 20px;
 +
  right: 30px;
 +
  z-index: 99;
 +
  font-size: 18px;
 +
  border: none;
 +
  outline: none;
 +
  background-color:transparent;
 +
  color: white;
 +
  cursor: pointer;
 +
  padding: 15px;
 +
  border-radius: 4px;
 +
}
  
<div class="column full_size">
+
#myBtn:hover {
 +
  background-color: #555;
 +
}
  
<h3>What information do I need to start putting my parts on the Registry?</h3>
+
table {
<p>The information needed to initially create a part on the Registry is:</p>
+
    font-family: arial, sans-serif;
<ul>
+
    border-collapse: collapse;
<li>Part Name</li>
+
    width: 100%;
<li>Part type</li>
+
}
<li>Creator</li>
+
<li>Sequence</li>
+
<li>Short Description (60 characters on what the DNA does)</li>
+
<li>Long Description (Longer description of what the DNA does)</li>
+
<li>Design considerations</li>
+
</ul>
+
  
<p>
+
td, th {
We encourage you to put up <em>much more</em> information as you gather it over the summer. If you have images, plots, characterization data and other information, please also put it up on the part page. </p>
+
    border: 1px solid #dddddd;
 +
    text-align: left;
 +
    padding: 8px;
 +
}
  
 +
tr:first-child {
 +
    background-color: #dddddd;
 +
</style>
 +
 +
<body>
 +
<button onclick="topFunction()" id="myBtn" title="Go to top"><img src="https://image.flaticon.com/icons/png/512/14/14747.png" style="width:50px;height:50px;"></button>
 +
 +
<!-- Navbar -->
 +
<nav class="navbar navbar-default">
 +
  <div class="navbar-inner">
 +
  <div class="container-fluid">
 +
    <div class="navbar-header">
 +
      <button type="button" class="navbar-toggle" data-toggle="collapse" data-target="#myNavbar">
 +
        <span class="icon-bar"></span>
 +
        <span class="icon-bar"></span>
 +
        <span class="icon-bar"></span>                       
 +
      </button>
 +
      <a class="navbar-brand" href="https://2018.igem.org/Team:UI_Indonesia">Home</a>
 +
    </div>
 +
    <div class="collapse navbar-collapse" id="myNavbar">
 +
      <ul class="nav navbar-nav navbar-right">
 +
        <li class="dropdown navbar-project">
 +
          <a href="https://2018.igem.org/Team:UI_Indonesia/Project">Project<span class="caret"></span></a>
 +
          <ul class="dropdown-menu">
 +
            <li><a href="https://2018.igem.org/Team:UI_Indonesia/Project#">Overview</a></li>
 +
            <li><a href="https://2018.igem.org/Team:UI_Indonesia/Project#ourproject">Our Project</a></li>
 +
            <li><a href="https://2018.igem.org/Team:UI_Indonesia/Project#resultsanddiscuccions">Results and Discussions</a></li>
 +
          </ul>
 +
        </li>
 +
        <li class="navbar-parts current"><a href="https://2018.igem.org/Team:UI_Indonesia/Parts">Parts</a></li>
 +
    <li class="navbar-safety"><a href="https://2018.igem.org/Team:UI_Indonesia/Safety">Safety</a></li>
 +
    <li class="dropdown navbar-interlab">
 +
          <a href="https://2018.igem.org/Team:UI_Indonesia/InterLab">InterLab<span class="caret"></span></a>
 +
          <ul class="dropdown-menu">
 +
            <li><a href="https://2018.igem.org/Team:UI_Indonesia/InterLab#intro">Introduction</a></li>
 +
            <li><a href="https://2018.igem.org/Team:UI_Indonesia/InterLab#materials">Materials and Equipment</a></li>
 +
            <li><a href="https://2018.igem.org/Team:UI_Indonesia/InterLab#methods">Methods</a></li>
 +
      <li><a href="https://2018.igem.org/Team:UI_Indonesia/InterLab#results">Results and Discussions</a></li>
 +
      <li><a href="https://2018.igem.org/Team:UI_Indonesia/InterLab#conclusions">Conclusions</a></li>
 +
          </ul>
 +
        </li>
 +
    <li class="navbar-model"><a href="https://2018.igem.org/Team:UI_Indonesia/Model">Model</a></li>
 +
    <li class="dropdown navbar-humanpractice">
 +
          <a href="https://2018.igem.org/Team:UI_Indonesia/Human_Practices">Human Practices<span class="caret"></span></a>
 +
          <ul class="dropdown-menu">
 +
            <li><a href="https://2018.igem.org/Team:UI_Indonesia/Human_Practices">Integrated Human Practice</a></li>
 +
            <li><a href="https://2018.igem.org/Team:UI_Indonesia/Public_Engagement">Education and Public Engagement</a></li>
 +
            <li><a href="https://2018.igem.org/Team:UI_Indonesia/Human_Practices#catalogue">Human Practice Catalogue</a></li>
 +
          </ul>
 +
    </li>
 +
    <li class="navbar-improve"><a href="https://2018.igem.org/Team:UI_Indonesia/Improve">Improve</a></li>
 +
    <li class="navbar-team"><a href="https://2018.igem.org/Team:UI_Indonesia/Team">Team</a></li>
 +
    <li class="navbar-collaborations"><a href="https://2018.igem.org/Team:UI_Indonesia/Collaborations">Collaborations</a></li>
 +
        <li class="dropdown navbar-attributions">
 +
          <a href="https://2018.igem.org/Team:UI_Indonesia/Attributions">Attributions<span class="caret"></span></a>
 +
          <ul class="dropdown-menu">
 +
            <li><a href="https://2018.igem.org/Team:UI_Indonesia/MedalCriteria">Medal Criteria</a></li>
 +
          </ul>
 +
        </li>
 +
      </ul>
 +
    </div>
 +
  </div>
 +
  </div>
 +
</nav>
 +
 +
<!-- Container (Affitoxin Section) -->
 +
<div class="bgimg-3 w3-display-container w3-opacity-min" id="affitoxin">
 +
  <div class="w3-display-middle" style="white-space:nowrap;">
 +
    <span class="w3-center w3-padding-large w3-black w3-xlarge w3-wide w3-animate-opacity">DIPHTOX</span>
 +
  </div>
 
</div>
 
</div>
  
 +
<div class="w3-content w3-container w3-padding-64">
 +
  <h5>Using the <i>wild-type</i> diphtheria exotoxin to characterize HB-EGF/Tar receptor could be harmful due to biosafety reason. To tackle this problem, our team design a much simplified diphtheria toxin by removing the domain that is deadly to the cell. This domain, named domain C, will be translocated into the cell with the aid of other domains in toxin called domain R and domain T. Additionally, R domain recognized the natural HBEGF receptor, and T domain will insert the C domain into the cell. Thus, C domain would catalyze NAD-dependent ADP-ribosylation of EF-2 and leads to cellular apoptosis<sup>1</sup>. This remodeled toxin, coined DiphTox, is incorporated in the plasmids (such as pSB1C3 and pEQ80L) along with the following parts.</h5><br>
  
<div class="clear extra_space"></div>
+
  <div class="w3-row w3-center">
<div class="line_divider"></div>
+
    <img src="https://static.igem.org/mediawiki/2018/5/54/T--UI_Indonesia--partsf1diphtox.png" class="w3-image" width="500">
<div class="clear extra_space"></div>
+
  <h6><b>Figure 1.</b> DiphTox Biobrick.</h6></div><br>
  
<div class="column full_size">
+
  <h5>Amplification of single biobrick are done via PCR cloning using ‘self-made’ universal forward (Primer Cloning Fwd) and reverse primers (Primer Cloning Rev). The following sequences are the primers for PCR cloning.</h5>
<h3>Part Table </h3>
+
  <br>
 +
  <div class="w3-row w3-center">
 +
    <table>
 +
      <tr>
 +
        <th>Primers</th>
 +
        <th>Sequence</th>
 +
        <th>Melting Temperatures (Tm)</th>
 +
        <th>GC Content (%)</th>
 +
        <th>Hairpin Structure Energy Formation (kcal/mol)</th>
 +
        <th>Self-dimer Energy Formation (kcal/mol)</th>
 +
      </tr>
 +
      <tr>
 +
        <td>Fwd Cloning</td>
 +
        <td>5’ AGTTCAAGTGTCCGAGAA 3’</td>
 +
        <td>60.2<sup>0</sup>C</td>
 +
        <td>44.4%</td>
 +
        <td>0.64</td>
 +
        <td>-3.61</td>
 +
      </tr>
 +
      <tr>
 +
        <td>Rev Cloning</td>
 +
        <td>5’ TAAGCGAGTGCCGTATTA 3’</td>
 +
        <td>60.1<sup>0</sup>C</td>
 +
        <td>44.4%</td>
 +
        <td>-1.36</td>
 +
        <td>-3.61</td>
 +
      </tr>
 +
    </table>
 +
    <h6><b>Table 1.</b> PCR Cloning Amplification Primers</h6>
 +
  </div>
 +
  <br>
 +
  <h5>Note: Both heterodimer energy formations are -3.61 kcal/mol. Additionally, the predicted specifications are based on <i>IDT Oligo Analyzer 3.1</i> <a href="https://sg.idtdna.com/calc/analyzer" style="color:blue">server.</a> PCR solution is predicted to contain 0.2 mM dNTP, 50 mM Na<sup>+</sup>, 5 mM Mg<sup>2+</sup>, and 0.3 mM oligos.
 +
  </h5><br>
  
<p>Please include a table of all the parts your team has made during your project on this page. Remember part characterization and measurement data must go on your team part pages on the Registry. </p>
+
  <h5>Confirmation of gBlocks insertion into plasmid could be confirmed using PCR colony method using following primer. Note that HbT1 Fwd and HbT2 Rev is the same primer used in HT fragments to do in DipthTox gBlocks.</h5>
 +
  <br>
 +
  <div class="w3-row w3-center">
 +
    <table>
 +
      <tr>
 +
        <th>Primers</th>
 +
        <th>Sequence</th>
 +
        <th>Melting Temperatures (Tm)</th>
 +
        <th>GC Content (%)</th>
 +
        <th>Hairpin Structure Energy Formation (kcal/mol)</th>
 +
        <th>Self-dimer Energy Formation (kcal/mol)</th>
 +
      </tr>
 +
      <tr>
 +
        <td>HbT1 Fwd</td>
 +
        <td>5’ CTTACGCTTCTGCCACAT 3’</td>
 +
        <td>61.7<sup>0</sup>C</td>
 +
        <td>50%</td>
 +
        <td>-0.84</td>
 +
        <td>-3.61</td>
 +
      </tr>
 +
      <tr>
 +
        <td>HbT2 Rev</td>
 +
        <td>5’ CCCCTGACTGAGCATGAT 3’</td>
 +
        <td>62.8<sup>0</sup>C</td>
 +
        <td>55.6%</td>
 +
        <td>0.57</td>
 +
        <td>-5.38</td>
 +
      </tr>
 +
    </table>
 +
    <h6><b>Table 2.</b> Detailed data for DiphTox PCR colony primers</h6><br>
 +
  </div>
 +
  <br>
 +
  <h5>Note: Both heterodimer energy formation exhibits -5.04 kcal/mol free energy.</h5><br>
  
</html>
+
  <h5>For iGEM biobrick submission, we would use prefix and suffix that contain EcoRI and PstI. Further characterization of the biobrick of DiphTox could be accessed via <a href="http://parts.igem.org/Part:BBa_K2607000" style="color:blue">http://parts.igem.org/Part:BBa_K2607000</a>. HindIII site and BamHI are inserted upstream from prefix and downstream from suffix respectively. The DiphTox contains only the last 54 amino acid from the R domain which has no cytotoxicity and significant enough to bind with HBEGF receptor<sup>2</sup>. At the downstream of the sequence, designing six histidine amino acids is essential for His-tag protein purification, as well as characterizing the DiphTox and HB-EGF/Tar receptor kinetics. Ribosome Binding Site (RBS) is located upstream within the gBlocks containing Shine-Dalgarno sequence as follow.<br>
<groupparts>iGEM18 UI_Indonesia</groupparts>
+
  RBS : 5' GAGCGGATTATATAAGGAGGTTAATC 3’
<html>
+
  </h5><br>
 
</div>
 
</div>
  
 +
<!-- Container (HB-EGF/Tar Section) -->
 +
<div class="bgimg-3 w3-display-container w3-opacity-min" id="hbegftar">
 +
  <div class="w3-display-middle" style="white-space:nowrap;">
 +
    <span class="w3-center w3-padding-large w3-black w3-xlarge w3-wide w3-animate-opacity">HB-EGF/Tar</span>
 +
  </div>
 +
</div>
  
 +
<div class="w3-content w3-container w3-padding-64">
 +
  <h5>HB-EGF/Tar is a synthetically combined receptor used as project’s diagnostic tool system. Since there was limitation in its biobrick construction (for its high DNA complexity and base pairs length as <i>gBlocks</i>), we separate the HB-EGF/Tar sequence into two fragments called HB-EGF/Tar Fragment 1 (HT-1) in the upstream, and the other one would be HB-EGF/Tar Fragment 2 (HT-2). The schematic structure of HT-1 biobrick is as follow.</h5><br>
 +
 +
  <div class="w3-row w3-center">
 +
    <img src="https://static.igem.org/mediawiki/2018/c/c3/T--UI_Indonesia--partsf2.png" class="w3-image" width="500">
 +
  <h6><b>Figure 2.</b> HB-EGF/Tar Fragment 1 Biobrick.</h6></div><br>
 +
 +
  <h5>The HT-1 fragment consist of 981 bp sequence that include <i>SalI</i> cutting site and specified PCR colony reverse primer (HbT1 rev). Amplification of single biobrick are done via PCR cloning using ‘self-made’ universal forward (Primer Cloning Fwd) and reverse primers (Primer Cloning Rev), which are the same as cloning primer for DiphTox gBlocks.</h5><br>
 +
 +
  <h5>For confirmation of this biobrick existence inside <i>E. coli</i>, PCR colony is essential, using specific primers named “PCR colony HbT1 fwd” for forward primer and “PCR colony HbT1 rev” for reverse primer. They are constructed using NCBI primer BLAST <a href="https://www.ncbi.nlm.nih.gov/tools/primer-blast/" style="color:blue">website.</a> The sequences are served as follows.</h5>
 +
  <br>
 +
  <div class="w3-row w3-center">
 +
    <table>
 +
      <tr>
 +
        <th>Primers</th>
 +
        <th>Sequence</th>
 +
        <th>Melting Temperatures (Tm)</th>
 +
        <th>GC Content (%)</th>
 +
        <th>Hairpin Structure Energy Formation (kcal/mol)</th>
 +
        <th>Self-dimer Energy Formation (kcal/mol)</th>
 +
      </tr>
 +
      <tr>
 +
        <td>HbT1 Fwd</td>
 +
        <td>5’ CTTACGCTTCTGCCACAT 3’</td>
 +
        <td>61.7<sup>0</sup>C</td>
 +
        <td>50%</td>
 +
        <td>-0.84</td>
 +
        <td>-3.61</td>
 +
      </tr>
 +
      <tr>
 +
        <td>HbT1 Rev</td>
 +
        <td>5’ TTCTTACGCTTCCCATGTTC 3’</td>
 +
        <td>62.1<sup>0</sup>C</td>
 +
        <td>45%</td>
 +
        <td>0.64</td>
 +
        <td>-5.38</td>
 +
      </tr>
 +
    </table>
 +
    <h6><b>Table 3.</b> Detailed data for HT1 PCR colony primers</h6><br>
 +
  </div>
 +
  <br>
 +
  <h5>Note: Both heterodimer energy formations are -4.77 kcal/mol.</h5><br>
 +
 +
  <h5>Biobrick RFC10 prefix is necessary and would be cut using EcoRI enzyme for submission. Active gene transcription includes highly expressing T7 constitutive promoter (Bba_I712074) located in the upstream part of HT-1. Ribosomal binding site (RBS) (Bba_B0034) functions to initiate direct HB-EGF/Tar translation (HbTf1-RBS). It is 18 bp in length with the following sequence, 5' AAAGAGGAGAAATACTAG 3’, conformed with Shine-Dalgarno sequence
 +
  <br>
 +
  The next fragment of HB-EGF/Tar Sequence, called HB-EGF/Tar Fragment 2 (HT-2), will be ligated exactly next to the first one via SalI restriction site. Schematic representation of HB-EGF/Tar Fragment 2 is as follow.</h5><br>
 +
 +
  <div class="w3-row w3-center">
 +
    <img src="https://static.igem.org/mediawiki/2018/0/04/T--UI_Indonesia--partsf3.png" class="w3-image" width="500">
 +
  <h6><b>Figure 3.</b> HB-EGF/Tar Fragment 2 Biobrick.</h6></div><br>
 +
 +
  <h5>To amplify this part, we would use universal PCR cloning forward and reverse primers with their sequences same as HT-1 and DiphTox gBlocks. PCR colony, with a specific primer named “HbT2 fwd” for forward primer and “HbT2 Rev” for reverse primer, could be used to confirm any successful transformation of ligated insert. Both primers are constructed with NCBI primer BLAST website and have the sequence detailed below.</h5>
 +
  <br>
 +
  <div class="w3-row w3-center">
 +
    <table>
 +
      <tr>
 +
        <th>Primers</th>
 +
        <th>Sequence</th>
 +
        <th>Melting Temperatures (Tm)</th>
 +
        <th>GC Content (%)</th>
 +
        <th>Hairpin Structure Energy Formation (kcal/mol)</th>
 +
        <th>Self-dimer Energy Formation (kcal/mol)</th>
 +
      </tr>
 +
      <tr>
 +
        <td>HbT2 Fwd</td>
 +
        <td>5’ GTTAGCGGTCTCAGAAATGG 3’</td>
 +
        <td>62.2<sup>0</sup>C</td>
 +
        <td>50%</td>
 +
        <td>-1.15</td>
 +
        <td>-3.61</td>
 +
      </tr>
 +
      <tr>
 +
        <td>HbT2 Rev</td>
 +
        <td>5’ CCCCTGACTGAGCATGAT 3’</td>
 +
        <td>62.8<sup>0</sup>C</td>
 +
        <td>55.6%</td>
 +
        <td>0.57</td>
 +
        <td>-5.38</td>
 +
      </tr>
 +
    </table>
 +
    <h6><b>Table 4.</b> detailed data for HT2 PCR colony primers</h6><br>
 +
  </div>
 +
  <br>
 +
  <h5>Note: Both heterodimer energy formations are -6.73 kcal/mol.</h5><br>
 +
 
 +
  <h5>In this fragment, SalI and NdeI are in upstream and downstream respectively. This arrangement would enable that HB-EGF/Tar frag 1 and HB-EGF/Tar frag 2 be next to each other and transcribed as a unity. At the end part of the coding region we add double terminator rrnB T1 and T7TE terminator (Bba_B0015). These terminators have been known to effectively terminate transcription of any gene. We shall submit the overall HB-EGF/Tar biobrick sequence by inserting iGEM registered RFC10 suffix that contain PstI restriction site at the downstream of the coding region. The prefix, as mentioned earlier, is inserted in the first fragment of the HB-EGF/Tar sequence. Further characterization of the biobrick of complete HB-EGF/Tar synthetic gene could be accessed via Further characterization of the biobrick of DiphTox could be accessed via <a href="http://parts.igem.org/Part:BBa_K2607001" style="color:blue">http://parts.igem.org/Part:BBa_K2607001</a>.
 +
  </h5><br>
 +
 +
  <h5><b>Reference</b>
 +
    <ol class="ref">
 +
      <li>Gillet D, Barbier J. Diphtheria toxin. The Comprehensive Sourcebook of Bacterial Protein Toxins. 2015;:111-132.</li>
 +
      <li>2.  Rolf J, Eidels L. Characterization of the diphtheria toxin receptor-binding domain. Molecular Microbiology. 1993;7(4):585-591.</li>
 +
    </ol></h5>
 +
</div>
 +
  <script src="https://ajax.googleapis.com/ajax/libs/jquery/3.3.1/jquery.min.js"></script>
 +
  <script src="https://maxcdn.bootstrapcdn.com/bootstrap/3.3.7/js/bootstrap.min.js"></script>
 +
<script>
 +
// When the user scrolls down 20px from the top of the document, show the button
 +
window.onscroll = function() {scrollFunction()};
  
 +
function scrollFunction() {
 +
    if (document.body.scrollTop > 20 || document.documentElement.scrollTop > 20) {
 +
        document.getElementById("myBtn").style.display = "block";
 +
    } else {
 +
        document.getElementById("myBtn").style.display = "none";
 +
    }
 +
}
  
 +
// When the user clicks on the button, scroll to the top of the document
 +
function topFunction() {
 +
    document.body.scrollTop = 0;
 +
    document.documentElement.scrollTop = 0;
 +
}
 +
</script>
 +
<!-- Footer -->
 +
<footer class="w3-center w3-green w3-padding-64 w3-opacity w3-hover-opacity-off">
 +
  <div class="w3-xlarge w3-section">Team UI Indonesia<br>
 +
    <i class="fa fa-envelope w3-hover-opacity"></i>&ensp; igemui2018@gmail.com
 +
  </div>
 +
</footer>
 +
</body>
 
</html>
 
</html>

Latest revision as of 08:11, 17 October 2018

DIPHTOX
Using the wild-type diphtheria exotoxin to characterize HB-EGF/Tar receptor could be harmful due to biosafety reason. To tackle this problem, our team design a much simplified diphtheria toxin by removing the domain that is deadly to the cell. This domain, named domain C, will be translocated into the cell with the aid of other domains in toxin called domain R and domain T. Additionally, R domain recognized the natural HBEGF receptor, and T domain will insert the C domain into the cell. Thus, C domain would catalyze NAD-dependent ADP-ribosylation of EF-2 and leads to cellular apoptosis1. This remodeled toxin, coined DiphTox, is incorporated in the plasmids (such as pSB1C3 and pEQ80L) along with the following parts.

Figure 1. DiphTox Biobrick.

Amplification of single biobrick are done via PCR cloning using ‘self-made’ universal forward (Primer Cloning Fwd) and reverse primers (Primer Cloning Rev). The following sequences are the primers for PCR cloning.

Primers Sequence Melting Temperatures (Tm) GC Content (%) Hairpin Structure Energy Formation (kcal/mol) Self-dimer Energy Formation (kcal/mol)
Fwd Cloning 5’ AGTTCAAGTGTCCGAGAA 3’ 60.20C 44.4% 0.64 -3.61
Rev Cloning 5’ TAAGCGAGTGCCGTATTA 3’ 60.10C 44.4% -1.36 -3.61
Table 1. PCR Cloning Amplification Primers

Note: Both heterodimer energy formations are -3.61 kcal/mol. Additionally, the predicted specifications are based on IDT Oligo Analyzer 3.1 server. PCR solution is predicted to contain 0.2 mM dNTP, 50 mM Na+, 5 mM Mg2+, and 0.3 mM oligos.

Confirmation of gBlocks insertion into plasmid could be confirmed using PCR colony method using following primer. Note that HbT1 Fwd and HbT2 Rev is the same primer used in HT fragments to do in DipthTox gBlocks.

Primers Sequence Melting Temperatures (Tm) GC Content (%) Hairpin Structure Energy Formation (kcal/mol) Self-dimer Energy Formation (kcal/mol)
HbT1 Fwd 5’ CTTACGCTTCTGCCACAT 3’ 61.70C 50% -0.84 -3.61
HbT2 Rev 5’ CCCCTGACTGAGCATGAT 3’ 62.80C 55.6% 0.57 -5.38
Table 2. Detailed data for DiphTox PCR colony primers


Note: Both heterodimer energy formation exhibits -5.04 kcal/mol free energy.

For iGEM biobrick submission, we would use prefix and suffix that contain EcoRI and PstI. Further characterization of the biobrick of DiphTox could be accessed via http://parts.igem.org/Part:BBa_K2607000. HindIII site and BamHI are inserted upstream from prefix and downstream from suffix respectively. The DiphTox contains only the last 54 amino acid from the R domain which has no cytotoxicity and significant enough to bind with HBEGF receptor2. At the downstream of the sequence, designing six histidine amino acids is essential for His-tag protein purification, as well as characterizing the DiphTox and HB-EGF/Tar receptor kinetics. Ribosome Binding Site (RBS) is located upstream within the gBlocks containing Shine-Dalgarno sequence as follow.
RBS : 5' GAGCGGATTATATAAGGAGGTTAATC 3’

HB-EGF/Tar
HB-EGF/Tar is a synthetically combined receptor used as project’s diagnostic tool system. Since there was limitation in its biobrick construction (for its high DNA complexity and base pairs length as gBlocks), we separate the HB-EGF/Tar sequence into two fragments called HB-EGF/Tar Fragment 1 (HT-1) in the upstream, and the other one would be HB-EGF/Tar Fragment 2 (HT-2). The schematic structure of HT-1 biobrick is as follow.

Figure 2. HB-EGF/Tar Fragment 1 Biobrick.

The HT-1 fragment consist of 981 bp sequence that include SalI cutting site and specified PCR colony reverse primer (HbT1 rev). Amplification of single biobrick are done via PCR cloning using ‘self-made’ universal forward (Primer Cloning Fwd) and reverse primers (Primer Cloning Rev), which are the same as cloning primer for DiphTox gBlocks.

For confirmation of this biobrick existence inside E. coli, PCR colony is essential, using specific primers named “PCR colony HbT1 fwd” for forward primer and “PCR colony HbT1 rev” for reverse primer. They are constructed using NCBI primer BLAST website. The sequences are served as follows.

Primers Sequence Melting Temperatures (Tm) GC Content (%) Hairpin Structure Energy Formation (kcal/mol) Self-dimer Energy Formation (kcal/mol)
HbT1 Fwd 5’ CTTACGCTTCTGCCACAT 3’ 61.70C 50% -0.84 -3.61
HbT1 Rev 5’ TTCTTACGCTTCCCATGTTC 3’ 62.10C 45% 0.64 -5.38
Table 3. Detailed data for HT1 PCR colony primers


Note: Both heterodimer energy formations are -4.77 kcal/mol.

Biobrick RFC10 prefix is necessary and would be cut using EcoRI enzyme for submission. Active gene transcription includes highly expressing T7 constitutive promoter (Bba_I712074) located in the upstream part of HT-1. Ribosomal binding site (RBS) (Bba_B0034) functions to initiate direct HB-EGF/Tar translation (HbTf1-RBS). It is 18 bp in length with the following sequence, 5' AAAGAGGAGAAATACTAG 3’, conformed with Shine-Dalgarno sequence
The next fragment of HB-EGF/Tar Sequence, called HB-EGF/Tar Fragment 2 (HT-2), will be ligated exactly next to the first one via SalI restriction site. Schematic representation of HB-EGF/Tar Fragment 2 is as follow.

Figure 3. HB-EGF/Tar Fragment 2 Biobrick.

To amplify this part, we would use universal PCR cloning forward and reverse primers with their sequences same as HT-1 and DiphTox gBlocks. PCR colony, with a specific primer named “HbT2 fwd” for forward primer and “HbT2 Rev” for reverse primer, could be used to confirm any successful transformation of ligated insert. Both primers are constructed with NCBI primer BLAST website and have the sequence detailed below.

Primers Sequence Melting Temperatures (Tm) GC Content (%) Hairpin Structure Energy Formation (kcal/mol) Self-dimer Energy Formation (kcal/mol)
HbT2 Fwd 5’ GTTAGCGGTCTCAGAAATGG 3’ 62.20C 50% -1.15 -3.61
HbT2 Rev 5’ CCCCTGACTGAGCATGAT 3’ 62.80C 55.6% 0.57 -5.38
Table 4. detailed data for HT2 PCR colony primers


Note: Both heterodimer energy formations are -6.73 kcal/mol.

In this fragment, SalI and NdeI are in upstream and downstream respectively. This arrangement would enable that HB-EGF/Tar frag 1 and HB-EGF/Tar frag 2 be next to each other and transcribed as a unity. At the end part of the coding region we add double terminator rrnB T1 and T7TE terminator (Bba_B0015). These terminators have been known to effectively terminate transcription of any gene. We shall submit the overall HB-EGF/Tar biobrick sequence by inserting iGEM registered RFC10 suffix that contain PstI restriction site at the downstream of the coding region. The prefix, as mentioned earlier, is inserted in the first fragment of the HB-EGF/Tar sequence. Further characterization of the biobrick of complete HB-EGF/Tar synthetic gene could be accessed via Further characterization of the biobrick of DiphTox could be accessed via http://parts.igem.org/Part:BBa_K2607001.

Reference
  1. Gillet D, Barbier J. Diphtheria toxin. The Comprehensive Sourcebook of Bacterial Protein Toxins. 2015;:111-132.
  2. 2. Rolf J, Eidels L. Characterization of the diphtheria toxin receptor-binding domain. Molecular Microbiology. 1993;7(4):585-591.
Team UI Indonesia
  igemui2018@gmail.com